-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The U.
Highlights of the report are summarized below:
Production Site Statistics: Over the past three years, the top five countries on the list (USA, India, China, Germany and Canada) saw net growth
Drug Statistics: In FY2021, the catalog contained 12,428 ANDAs, 3,537 NDA and 315 BAS
Quality Condition Study: OPQ's analysis reveals the relationship between on-site inspections and recalls
In FY21, the percentage of non-compliant samples was 35%, 16% higher than in FY2020 due to: nitrosamine-contaminated products, high non-compliance rates for hand sanitizers, and more
The FDA has made progress in two initiatives (NIPP and QMM) that are building better tools to characterize the quality of drug manufacturing sites
.